Details
Stereochemistry | ACHIRAL |
Molecular Formula | C32H39N7O4 |
Molecular Weight | 585.6966 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C3=CN(C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
InChI
InChIKey=AZSRSNUQCUDCGG-UHFFFAOYSA-N
InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36)
Molecular Formula | C32H39N7O4 |
Molecular Weight | 585.6966 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:21:30 GMT 2023
by
admin
on
Sat Dec 16 10:21:30 GMT 2023
|
Record UNII |
39HBQ4A67L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
653018
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1847461-43-1
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
JK-22
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
2570736
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
DTXSID201336749
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
118607832
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
C126752
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
300000010812
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
39HBQ4A67L
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
39HBQ4A67L
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY | |||
|
11183
Created by
admin on Sat Dec 16 10:21:30 GMT 2023 , Edited by admin on Sat Dec 16 10:21:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR -> TARGET |
Approved for treatment of EGFR EXON 20 insertions mutations in NSLC
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |